Blackrock Neurotech acquires MindX to aid creation of brain-computer interface products
Click Here to Manage Email Alerts
In a company press release, Blackrock Neurotech announced the acquisition of spatial computing software firm MindX to bolster its development of technologically advanced brain-computer interface products.
“By fusing our hardware DNA with their software DNA, we enhance our neural data analysis and enable flexibility and customization for a variety of BCI applications,” Marcus Gerhardt, Blackrock co-founder and CEO, said in the release. “Furthermore, the opportunity to broaden applications through spatial software and [augmented reality] exponentially advances our commercialization aims.”
According to the release, BCI use in clinical applications is supported by user-friendly software that decodes neural activity and translates brain signals into digital commands, which MindX provides with its proprietary spatial neurocomputing technology. When used in combination with decoded biological data, this integrated BCI platform has the potential to boost interaction between patients, their physical environments and the digital world and offer hope for increased quality of life and autonomy.
“I can’t think of a better way to get this technology into the hands of patients who need it than by bringing two talented teams together and melding Blackrock hardware with MindX software capabilities,” Julia Brown, founder and CEO of MindX, said in the release.
Blackrock anticipates releasing MoveAgain, the first commercial BCI platform, in early 2023.